Open AccessDOAJ SealDOAJCrossrefOpenAlex
Molecular Therapy: Oncology
Metadata for this journal is being automatically enriched from connected scholarly data sources.
Journal information
- Publisher
- Elsevier
- Subjects
- cancer · cancer biology · Cancer Immunotherapy and Biomarkers · Cancer Research and Treatments · CAR-T cell therapy research · gene therapy · Immune Cell Function and Interaction · immunotherapy · Immunotherapy and Immune Responses · molecular therapy · Monoclonal and Polyclonal Antibodies Research · Neoplasms. Tumors. Oncology. Including cancer and carcinogens · oncology · RC254-282 · Viral Infectious Diseases and Gene Expression in Insects · Virus-based gene therapy research
- Country
- US
- Languages
- EN
- ISSN
- 2950-3299
- E-ISSN
- 2950-3299
- ISSN-L
- 2950-3299
- Open access
- Yes
- OA since
- 2024
- Publication years
- 1998–2026
- APC (summary)
- —
- Website
- Visit journal ↗
Journal Classification
Classification is derived from this journal’s 2024–2025 publications using the OpenAlex taxonomy.
- Classification
- Field / Subfield
- Primary Field
- Biochemistry, Genetics and Molecular Biology
- Primary Subfield
- Genetics
- Domain
- Life Sciences
- Confidence
- Low
- Publications classified
- 318
- Classification version
- OAJF Classification v1.1
APC records
- OPENALEX · 2026
- 3,610 EUR
- OPENALEX · 2026
- 3,120 GBP
- OPENALEX · 2026
- 483,720 JPY
- OPENALEX · 2026
- 3,900 USD
- DOAJ · 2026
- 3,900 USD
